The Holy Grail of Cataract Surgery
Accommodative intraocular lenses under investigation show promise for restoring a full range of vision in the pseudophakic patient.
-
By
-
Despoina Theotoka, MD, MSc
-
Kendall E. Donaldson, MD, MS
-
September 1, 2025
-
Clinical Scorecard: The Holy Grail of Cataract Surgery
At a Glance
| Category | Detail |
|---|
| Condition | Presbyopia in pseudophakic patients |
| Key Mechanisms | Restoration of accommodation through innovative intraocular lenses (IOLs) |
| Target Population | Aging patients undergoing cataract surgery |
| Care Setting | Ophthalmology clinics and surgical centers |
Key Highlights
- Accommodating IOLs aim to restore natural vision lost to presbyopia.
- Multiple innovative accommodating IOLs are in development or early use.
- Clinical outcomes are promising but not yet definitive.
Guideline-Based Recommendations
Diagnosis
- Assess presbyopia in patients undergoing cataract surgery.
Management
- Consider accommodating IOLs for restoration of vision in pseudophakic patients.
Monitoring & Follow-up
- Evaluate visual acuity and accommodation post-implantation.
Risks
- Monitor for mixed clinical outcomes and potential complications.
Patient & Prescribing Data
Pseudophakic patients with presbyopia
Accommodating IOLs like FluidVision, Juvene, OmniVu, and JelliSee show varying degrees of success in restoring vision.
Clinical Best Practices
- Utilize FDA-approved accommodating lenses where applicable.
- Engage in ongoing clinical trials for emerging IOL technologies.
- Monitor patient outcomes closely to assess lens performance.
References
